DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Friday 30 September 2016

Dr. Rajappa Vaidyanathan



Dr. Rajappa Vaidyanathan


Group Director-Chemical, Synthetic and Analytical Development at Bristol-Myers Squibb

Director and Head-Process Research and Development, Bristol-Myers Squibb, India

Bristol-Myers Squibb

https://in.linkedin.com/in/rajappa-vaidyanathan-b6a4283
rajappa.vaidyanathan@bms.com







Scott Rychnovsky

srychnov@uci.edu
Professor
(949) 824-8292
1139 Natural Sciences II,3038B Frederick Reines Hall
Position: 
 Faculty



Experience






Director-Early Phase Chemical Development

Bristol-Myers Squibb
 –  (2 years 5 months)Bangalore, India





Head-Process Research and Development

Bristol-Myers Squibb
 –  (1 year 7 months)Bangalore





Associate Research Fellow

Pfizer
 –  (11 years 6 months)

Education





Indian Institute of Technology, Madras

Master of Science (M.Sc.), Chemistry




Development of Safe, Robust, Environmentally Responsible Processes for New Chemical Entities
- Dr. V. Rajappa, Director & Head-Process R&D, Bristol-Myers Squibb, India

A PRESENTATION



Image result for scroll up arrow

Scroll with mouse to view 76 pages





13.11.2015: An extension lecture by Dr.Rajappa Vaidyanathan; organized by department of Chemical Engineering & Chemistry.

Image result for Biocon BMS Research Centre,

Image result for Biocon BMS Research Centre,
KIRAN SHAW, OWNER, BIOCON

/////////

Thursday 29 September 2016

Bhaskar Reddy Guntoori, Ph.D.

028

Bhaskar Reddy Guntoori, Ph.D.
Senior Vice President, Process Chemistry





Dr. Bhaskar R. Guntoori joined Pharmaron as a Vice President of Process Chemistry in July 2011, and promoted to Senior Vice Presidnet in January 2016. 
Prior to this appointment, Dr. Guntoori was a Senior Manager, R&D at ApotexPharmachem, Brantford, Canada. 
He started at ApotexPharmachem in 1995 as a Chemist, held several positions within the Process R&D group before being promoted to Senior Manager R&D in 2004. 

He was one of the principal contributors to the growth of the R&D team from less than ten members in 1995 to a group of eighty scientists. He oversaw the successful completion of more than forty API projects, from lab scale process development to scale-up and commercialization and contributed significantly to the growth of intellectual property of the company.   

Dr. Guntoori received his Ph.D. in organic chemistry in 1988 from the University of Poona, India. Subsequently, he joined Sagami Chemical Research Centre, Japan to pursue industrial position under the advisory of Prof. T. Hiyama (1988-1990). 
He then joined Prof. Steve Hanessian’s group at the University of Montreal (1990-1994).
Dr. Guntoori’s expertise covers broad area of synthetic chemistry, such as medicinal chemistry, total synthesis, methodologies and Process R&D. His research work is published in 14 peer-reviewed scientific journals and he is a co-inventor/co-author of more than 88 internationally issued patents/patent applications. 

About Pharmaron
Pharmaron is a private, premier R&D service provider for the life science industry. Founded in 2003, Pharmaron has invested in its people and facilities, and established a broad spectrum of drug R&D service capabilities, ranging from synthetic and medicinal chemistry, biology, DMPK, pharmacology, safety assessment, radiochemistry and radiolabelled metabolism to chemical & pharmaceutical development. With about 4,000 employees and operations in China, the U.S. and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. For more information, please visit: www.pharmaron.com
Image result for pharmaron
Image result for pharmaron
Image result for pharmaron

///////

Tuesday 27 September 2016

SUNITHA VYALA

SUNITHA VYALA

SUNITHA VYALA

Senior Scientist at Dr. Reddy's Laboratories



Dr. Reddy's Laboratories

Experience




Senior Scientist

Dr. Reddy's Laboratories
 – Present (7 years 9 months)BACHUPALLY, HYDERABAD
SCREENING AND DEVELOPMENT OF POLYMORPHS DURING THE PRODUCT DEVELOPMENT OF ACTIVE PHARMACEUTICAL INGREDIENTS
Literature search, Product Development of the Active Pharmaceutical Ingredients includes gram scale development of APIs to Kilogram scale applying the QbD principles and DoE applications.
Usage of PAT tools to understand and monitor the reactions. Development of the product by the usage of eco-friendly solvents and cheaply available chemicals.



postdoctorant

CNRS
 –  (1 year)Rennes
Ionic liquids, Task Specific Onium salts, Continuous micro reactors and biocatalysis


Scientist

SAI Life Sciences Ltd
 –  (6 months)Shamirpet, Hyderabad
Synthesis of biologically active compounds

Education



Nalsar University of Law

Post-Graduate Diploma in Patents Law

Patents Law



Indian institute of chemical technology

Doctor of Philosophy (PhD), Sythetic organic chemistry

Development of novel synthetic methodologies and its application towards the total synthesis of Scytophycin-C


University of Hyderabad

Post Graduate Diploma in Environmental Management, Environmental Science
Photo:

Research experience

  • Oct 2009–
    Dec 2014
    SCIENTIST
    Dr. Reddy's Laboratories · Research & Development
    India · Hyderabad
  • Sep 2008–
    Aug 2009
    Post doctorant
    French National Centre for Scientific Research · Michel Vaultier
    France · Rennes, Brittany
    Ionic liquids and Task specific onium salts
  • Feb 2008–
    Jul 2008
    Senior research associate
    SAI Life Sciences Ltd · Research and development
    India · Shamirpet
    Synthesis of biologically active molecules
  • Mar 2002–
    Dec 2007
    Research fellow
    Indian Institute of Chemical Technology · Natural Products Chemistry Group (IICT) · Dr. J.S Yadav group
    India · Hyderabad
















Processes for the preparation of agomelatine and its intermediates 
EP 2562151 A1

Publication numberEP2562151 A1
Publication typeApplication
Application numberEP20120181650
Publication date27 Feb 2013
Filing date24 Aug 2012
Priority date25 Aug 2011
InventorsPraveen CherukupallySunitha VyalaSatish Kumar VujjiniVenkata Krishna Rao Badarla,Sreenadha Charyulu KandalaVenkata Rama Krishnam Raju DatlaVenu NalivelaLess «
ApplicantDr. Reddy's Laboratories Ltd.
Export CitationBiBTeXEndNoteRefMan
External Links: EspacenetEP Register
ABSTRACT
Aspects of the present application relate to processes for the preparation of agomelatine and its intermediates which are used in manufacturing process of agomelatine.



Chemistry & Biology Interface


July-August 2012, Volume 2, No.4



July-August 2012, Volume 2, No.4
Chemistry & Biology Interface, 2012, 2, 4, 206-257
(ISSN: 2249 – 4820)

An alternative route for the synthesis of N-substituted iminosugar derivative, miglitol
Ganta Madhusudhan Reddy, V.V.N.K.V. Prasada Raju, Kisara Satyanarayana, Vedantham Ravindra, Sunitha Vyala, G.Venkateshwarlu

[Full Text-PDF]
link.......http://cbijournal.com/index.php/archive/21-july-august-2012-volume-2-no4








Publications














Some pictures............












Image result for osmania university logo

Image result for Osmania University
Image result for Osmania University


Image result for cnrs rennes france



Image result for Centre national de la recherche scientifique




///////////